tradingkey.logo

Azenta Inc

AZTA
View Detailed Chart

32.340USD

-0.360-1.10%
Close 08/01, 16:00ETQuotes delayed by 15 min
1.48BMarket Cap
LossP/E TTM

Azenta Inc

32.340

-0.360-1.10%
Intraday
1m
30m
1h
D
W
M
D

Today

-1.10%

5 Days

-6.07%

1 Month

-2.68%

6 Months

-37.92%

Year to Date

-35.32%

1 Year

-43.00%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 8 analysts
HOLD
Current Rating
32.000
Target Price
-1.05%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

552
Total
5
Median
6
Average
Company name
Ratings
Analysts
Azenta Inc
AZTA
8
CRISPR Therapeutics AG
CRSP
29
Intellia Therapeutics Inc
NTLA
28
Exact Sciences Corp
EXAS
27
Ionis Pharmaceuticals Inc
IONS
27
IQVIA Holdings Inc
IQV
25
1
2
3
...
111

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Sell
Sell(7)
Neutral(3)
Buy(2)
Indicators
Sell(3)
Neutral(3)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-0.335
Neutral
RSI(14)
49.735
Neutral
STOCH(KDJ)(9,3,3)
41.883
Sell
ATR(14)
1.542
High Vlolatility
CCI(14)
-57.741
Neutral
Williams %R
66.890
Sell
TRIX(12,20)
0.350
Sell
StochRSI(14)
0.000
Oversold
Moving Average
Sell(4)
Neutral(0)
Buy(2)
Indicators
Value
Direction
MA5
33.302
Sell
MA10
33.362
Sell
MA20
32.952
Sell
MA50
30.838
Buy
MA100
30.565
Buy
MA200
38.794
Sell

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Azenta, Inc. is a provider of biological and chemical compound sample exploration and management solutions for the life sciences industry. The Sample Management Solutions segment offers end-to-end sample management products and services, including sample and repository services and core products (automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled rate thawing devices). The Multiomics segment provides genomic and other sample analysis services, including gene sequencing and synthesis editing and related services. The B Medical Systems segment is focused on the manufacturing and distribution of temperature-controlled storage and transportation solutions in international markets to governments, health institutions, and non-government organizations. The Company provides products and services through its brands, including GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, Barkey, and B Medical Systems.
Ticker SymbolAZTA
CompanyAzenta Inc
CEOMr. John Marotta
Websitehttps://www.azenta.com/
KeyAI